--- title: Profil World - The clinical diabetes research newsletter - November 2019 description: "Latest \"Profil World\" edition about our recent publication on fast-acting insulin aspart and the news in the treatment of type 2 diabetes presented at the EASD 2019." image: https://blog.profil.com/hubfs/BLUE_MOON/Header/Header_1077x260px_About_Profil.jpg --- [![profil-logo-wortbild-with claim-4c-offset_1000px](https://blog.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px.png?width=250&name=profil-logo-wortbild-with%20claim-4c-offset_1000px.png "profil-logo-wortbild-with claim-4c-offset_1000px")](https://www.profil.com) [![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da) [Patient information](https://www.profil.de) ![Header_1077x260px_About_Profil.jpg](https://blog.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x260px_About_Profil.jpg?width=1077&name=Header_1077x260px_About_Profil.jpg "Header_1077x260px_About_Profil.jpg") # Profil World - The clinical diabetes research newsletter - November 2019 ![Svenya](https://blog.profil.com/hubfs/Svenya_Meister_Hexagon.png) Posted by [Svenya Meister](https://blog.profil.com/blog/author/svenya-meister) on Nov 26, 2019 5:18:00 PM ![Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.](https://cdn2.hubspot.net/hub/3825816/hubfs/BM/IN.png?width=20&name=IN.png "Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.") ![Two clicks for more privacy: The Twitter Share button will be enabled once you click here. Activating the button already sends data to Twitter.](https://blog.profil.com/hubfs/BLUE_MOON/twitter.png "Two clicks for more privacy: The Twitter Share button will be enabled once you click here. Activating the button already sends data to Twitter.") Dear all, Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity. ### Methodology fact sheet: Assessing energy expenditure [![Assessing energy expenditure_210x110](https://blog.profil.com/hs-fs/hubfs/Assessing%20energy%20expenditure_210x110.png?width=210&name=Assessing%20energy%20expenditure_210x110.png)](https://blog.profil.com/hubfs/PROFIL%20Assessing%20Energy%20Expenditure%20Fact%20Sheet%202019%20DIGITAL.pdf)Profil offers a portfolio of methods for evaluating each component of energy expenditure: Resting energy expenditure with indirect calorimetry, diet-induced thermogenesis with indirect calorimetry, activity-induced energy expenditure with spiroergometry, total energy expenditure with the double laebled water method. [Download our fact sheet](https://blog.profil.com/hubfs/PROFIL%20Assessing%20Energy%20Expenditure%20Fact%20Sheet%202019%20DIGITAL.pdf) for more information or [click here](https://www.profil.com/services/exercise-energy-expenditure) to browse our website on assessing energy expenditure. ### News in the treatment of type 2 diabetes presented at EASD 2019 [![medical-technolgoy-research_210x110](https://blog.profil.com/hs-fs/hubfs/medical-technolgoy-research_210x110.jpg?width=210&name=medical-technolgoy-research_210x110.jpg)](https://blog.profil.com/blog/news-in-the-treatment-of-type-2-diabetes)At the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain news in the treatment of type 2 diabetes were presented. We offer a selection of topics relevant for the field of type 2 diabetes mellitus discussed during that meeting. [Read our blog post](https://blog.profil.com/blog/news-in-the-treatment-of-type-2-diabetes) on the news of EASD 2019.   ### Profil recently published a study on fast-acting insulin aspart [![0090_RGB__](https://blog.profil.com/hs-fs/hubfs/0090_RGB__.jpg?width=210&name=0090_RGB__.jpg)](https://www.ncbi.nlm.nih.gov/pubmed/31667789)[Read our publication](https://www.ncbi.nlm.nih.gov/pubmed/31667789) on fast-acting insulin aspart. The publication contains a reviews of its pharmacokinetic and pharmacodynamic properties and the clinical consequences. The review considers 12 clinical pharmacological studies as well as 10 further studies of the later development program  of faster aspart. If you are interested in our other publications please [click here](https://www.profil.com/knowledge-center/publications). Meet us at upcoming conferences  [![Fotolia_14.06.2013_23704610__](https://blog.profil.com/hs-fs/hubfs/Fotolia_14.06.2013_23704610__.jpg?width=210&name=Fotolia_14.06.2013_23704610__.jpg)](https://info.profil.com/meet-profil-at-a-conference) Are you interested in knowing more about Profil? We attend all major conferences focused on diabetes, so if you are planning to go to any upcoming conference, we would love to [schedule a meeting](https://info.profil.com/meet-profil-at-a-conference) and tell you more about our expertise! [Upcoming events](https://www.profil.com/organisation/conferences): Biotech Showcase in San Francisco, USA (1/13-15/2020), ATTD in Madrid, Spain (2/19-22/2020)   We wish you a good week and look forward to the next "Profil World", Svenya Meister - Online Marketing Manager   Topics: [About Profil](https://blog.profil.com/blog/topic/about-profil) [Leave a comment](https://blog.profil.com/blog/profil-world-newsletter-november-2019#comment_form) ### Subscribe to Email Updates ### Our most popular Posts ### Posts by Topic - [Clinical Trials in Diabetes (127)](https://blog.profil.com/blog/topic/clinical-trials-in-diabetes) - [About Profil (69)](https://blog.profil.com/blog/topic/about-profil) - [Clinical Trial Methods (68)](https://blog.profil.com/blog/topic/clinical-trial-methods) - [The Science behind Diabetes (64)](https://blog.profil.com/blog/topic/the-science-behind-diabetes) - [Treating Diabetes (62)](https://blog.profil.com/blog/topic/treating-diabetes) - [Diabetes Technology (41)](https://blog.profil.com/blog/topic/diabetes-technology) - [Clinical trials in Obesity (11)](https://blog.profil.com/blog/topic/clinical-trials-in-obesity) - [Events (4)](https://blog.profil.com/blog/topic/events) - [CRO selection (2)](https://blog.profil.com/blog/topic/cro-selection) - [Regulatory Affairs (2)](https://blog.profil.com/blog/topic/regulatory-affairs) [see all](https://blog.profil.com/blog/profil-world-newsletter-november-2019#) ## You might also like this post ### ["What are glucose clamps and why do we need them?"](https://blog.profil.com/blog/what-are-glucose-clamps-and-why-do-we-need-them)